[1] Ming-Yang Lee,Muh-Hwa Yang,Jin-Hwang Liu, et al.Severe anaphylactic reactions in patients receiving oxaliplatin therapy: a rare but potentially fatal complication[J].Support Care Cancer 2007, 15(1): 89-93. [2] Alliot C, Messouak D, Beets C, et al.Severe anaphylactic reaction to oxaliplatin[J]. Clin Oncol (R Coll Radiol) ,2001(13):236. [3] Bhargava P, Gammon D, McCormick MJ. Hypersensitivity and idiosyncratic reactions to oxaliplatin[J]. Cancer, 2004(100):211-212. [4] Larzilliere I, Brandissou S, Breton P, et al.Anaphylactic reac- tion to oxaliplatin: a case report[J]. Am J Gastroenterol,1999(94): 3387-3388. [5] Lenz G, Hacker UT, Kern W, et al.Adverse reactions to oxaliplatin: a retrospective study of 25 patients treated in one institution[J]. Anticancer Drugs, 2003(14):731-733. [6] Lim KH, Huang MJ, Lin HC, et al.Hypersensitivity reactions to oxaliplatin: a case report and the success of a continuous infus- ional desensitization schedule[J]. Anticancer Drugs, 2004(15): 605-607. [7] Maindrault-Goebel F, Andre T, Tournigand C, et al.Allergic-type reactions to oxaliplatin: retrospective analysis of 42 patients[J]. Eur J Cancer, 2005(41):2262-2267. [8] Medioni J, Coulon MA, Morere JF, et al.Anaphylaxis after oxali- platin[J]. Ann Oncol, 1999(10):610. [9] Santini D, Tonini G, Salerno A, et al.Idio- syncratic reaction after oxaliplatin in- fusion[J]. Ann Oncol, 2001(12):132-133. [10] Schull B, Kornek GV, Scheithauer W.Idiosyncratic reaction after oxaliplatin: circumvention by use of a continuous infusional administration schedule[J]. Ann Oncol, 2001(12):1653-1654. [11] Siu SW, Chan RT, Au GK.Hypersensitivity reactions to oxalipla- tin: experience in a single institute[J]. Ann Oncol, 2006(17): 259-261. [12] Stahl M, Koster W, Wilke H.Reaction after oxaliplatin-prevention with corticosteroids?[J]. Ann Oncol, 2001(12):874. [13] Thomas RR, Quinn MG, Schuler B, et al.Hypersensitivity and idiosyncratic reactions to oxaliplatin[J]. Cancer, 2003(97): 2301-2307. [14] Tournigand C, Maindrault-Goebel F, Louvet C, et al.Severe anaphylactic reactions to oxaliplatin[J]. Eur J Cancer, 1998 (34):1297-1298. [15] Ring J, Messmer K.Incidence and severity of anaphylactoid reactions to colloid volume substitutes[J].Survey of Anes- thesiology, 1977,309(8009):466-469. [16] 华健,翟青,郭伟剑,等.我院56例奥沙利铂致不良反应报告分析[J].中国药房,2011,22(4):322. [17] Zhao Y, An X, Xiang XJ, et.al. Clinical features of hypersensitivity reactions to oxaliplatin among Chinese patients with colorectal cancer[J].Chinese Journal of Cancer,2010, 29(1):96-99. [18] Kim MY, Kang SY, Lee SY, et al.Hypersensitivity Reactions to Oxaliplatin: Clinical Features and Risk Factors in Koreans[J]. Asian Pacific Journal of Cancer Prevention, 2012, 13(4):1209-1215. [19] Saif MW. Hypersensitivity reactions associated with oxaliplatin[J]. Expert Opin Drug Saf, 2006, 5(5):687. [20] Edmondson DA, Gruling BJ, Urmanski AM, et al.Oxaliplatin by persensitivity:case report and successful repeat desensitization[J].Am J Ther, 2007(14):116-118. [21] 方英立,宫强强,周文,等.奥沙利铂过敏49例分析[J].中国新药与临床杂志,2010, 29(2):148-150. [22] Bhargava P, Gammon D, McCormick MJ. Hyoersensitivity and idiosyncratic reactions to oxaliplatin[J]. Cancer, 2004, 100(1): 211-212. [23] Gammon D, Bhargava P, McCormick MJ. Hypersensitivity reactions to oxaliplatin and the application of a desensitization protocol[J]. Oncologist, 2004, 9(5):546-549. [24] 马丽华,钱屹.延长奥沙利铂输注时间预防其外周神经毒性的临床研究[J].现代肿瘤医学,2014,22(10):2431-2433. [25] 吴朝晖,余慧茜,叶雪微.奥沙利铂不同输注速度外周神经毒性反应发生情况比较[J].护理学报,2006,13(4):70-71. [26] 孙密芬,赵燕,饶爱华,等.奥沙利铂致过敏反应15例临床分析[J].海峡药学,2012,24(9):264-265. [27] 广东省药学会.铂类药物临床应用与不良反应管理专家共识[Z].2018. [28] 赵阳,安欣,向晓娟,等.中国结直肠癌患者奥沙利铂过敏反应的临床特征[J].癌症,2010,29(1):102-105. [29] 张帆,周文琴.《ESMO临床实践指南:系统性抗癌治疗输液反应的管理(2017版)》解读[J].护理学杂志,2018,33(17):15-19. [30] 紫杉醇之际超敏反应预处理指导意见专家组.紫杉醇制剂超敏反应预处理指导意见[J].中国现代应用药学,2019,36(8):1023-1027. |